Page 182 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Liver Tumours: Clinical (Epidemiology, Diagnosis) (Cont.)

YI P0361 HOST GENETIC POLYMORPHISMS WITH
HEPATOCELLULAR CARCINOMA RISK IN CHINESE HAN
POPULATION: A CASE-CONTROL STUDY
Yun Liao*, Bei Cai,Yi Li, Jie Chen, Lanlan Wang, China

YI P0362 HEPATOCELLULAR CARCINOMA INCIDENCE IN CHRONIC
HEPATITIS C PATIENTS ACCORDING TO ANTIVIRAL
TREATMENT STATUS
Tuul Purevsambuu*, Simona Bota, Florian Hucke, Harald Hofer,
Peter Ferenci, Wolfgang Sieghart, Markus Peck-Radosavljevic, Austria

YI P0363 SYSTEMATIC REVIEW AND META-ANALYSIS OF
INCIDENCE AND RISK FACTORS OF HEPATOCELLULAR
CARCINOMA IN UNTREATED HBV INFECTED PATIENTS
Elena Raffetti*, Giovanna Fattovich, Francesco Donato, Italy

YI P0364 CLINIC EVALUATION OF CIRCULATING MICRORNAS
AS POTENTIAL BIOMARKERS OF HEPATOCELLULAR
ePOSTERS CARCINOMA IN PATIENTS WITH HBV CHRONIC
INFECTION
Gian Paolo Caviglia*, Maria Lorena Abate, Elisa Petrini, Silvia Gaia,
Paola Manzini, Patrizia Carucci, Mario Rizzetto, Antonina Smedile, Italy

YI P0365 EFFECTS OF METFORMIN ON CLINICAL OUTCOME IN
ADVANCED HCC PATIENTS RECEIVING SORAFENIB
Andrea Caadei Gardini*, Mario Scartozzi, Emanuela Scarpi,
Giorgia Marisi, Luca Faloppi, Stefano Tamberi, Emiliano Tamburini,
Gianluca Masi, Francesco Giuseppe Foschi, Nicola Silvestris, Paola Ulivi,
Giovanni Luca Frassineti, Italy

YI P0366 HEPATITIS C TREATMENT AND FIBROSIS STAGE IN
SUBJECTS WITH HEPATOCELLULAR CARCINOMA
AND HEPATITIS C IN A SINGLE U.S. CENTER VETERAN
POPULATION
Anupama U. Nookala*, Nabiha S. Shamsi, Krista M. Newman,
Astrid Knott-Johnson, Paola Ricci, The United States

182 The International Liver Congress™ 2015 • ILC Programme